Literature DB >> 11750598

Glycine reduces reperfusion injury in human liver transplantation: our first patients.

P Schemmer1, M Golling, T Kraus, E Mayatepek, C Herfarth, E Klar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11750598     DOI: 10.1016/s0041-1345(01)02588-x

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

Review 1.  Glycine, a simple physiological compound protecting by yet puzzling mechanism(s) against ischaemia-reperfusion injury: current knowledge.

Authors:  Frank Petrat; Kerstin Boengler; Rainer Schulz; Herbert de Groot
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

2.  HTK-N, a modified HTK solution, decreases preservation injury in a model of microsteatotic rat liver transplantation.

Authors:  Qinlong Liu; Helge Bruns; Daniel Schultze; Yi Xue; Markus Zorn; Christa Flechtenmacher; Beate K Straub; Ursula Rauen; Peter Schemmer
Journal:  Langenbecks Arch Surg       Date:  2012-11-01       Impact factor: 3.445

3.  Glycine and glycine receptor signalling in non-neuronal cells.

Authors:  Jimmy Van den Eynden; Sheen Saheb Ali; Nikki Horwood; Sofie Carmans; Bert Brône; Niels Hellings; Paul Steels; Robert J Harvey; Jean-Michel Rigo
Journal:  Front Mol Neurosci       Date:  2009-08-20       Impact factor: 5.639

Review 4.  Control of Ischemia-Reperfusion Injury in Liver Transplantation: Potentials for Increasing the Donor Pool.

Authors:  Judith Kahn; Peter Schemmer
Journal:  Visc Med       Date:  2018-10-30

5.  HEGPOL: randomized, placebo controlled, multicenter, double-blind clinical trial to investigate hepatoprotective effects of glycine in the postoperative phase of liver transplantation [ISRCTN69350312].

Authors:  Steffen P Luntz; Kristina Unnebrink; Monika Seibert-Grafe; Hartwig Bunzendahl; Thomas W Kraus; Markus W Büchler; Ernst Klar; Peter Schemmer
Journal:  BMC Surg       Date:  2005-08-17       Impact factor: 2.102

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.